Effect of probiotics on preventing disruption of the intestinal microflora following antibiotic therapy: A double-blind, placebo-controlled pilot study
Abstract
In this pilot-scale, double-blind, placebo-controlled trial, 30 patients with Helicobacter pylori infection were randomised into three groups prior to their 7 days eradication therapy, to study the effects of probiotic supplement comprising Lactobacillus acidophilus and Bifidobacterium bifidum on the intestinal microflora in response to antibiotic therapy. Group I received the placebo product from day 1 to day 15, Group II received placebo from day 1 to day 7 and probiotics from day 8 to day 15 and Group III received probiotics from day 1 to day 15. Patients provided stool samples for analysis on days 1, 7, 12, 17 and 27. For patients in Groups I and II, significant increases in the facultative anaerobe component of the microflora occurred between days 1 and 7. In Group I, the numbers remained elevated to day 27 but in Group II, the numbers decreased significantly between days 7 and 27 back to the starting levels. In Group III, the facultative anaerobe population remained stable throughout. The total anaerobe numbers increased significantly at day 27 than at day 1 for Group I, were unchanged throughout for Group II and decreased significantly for the patients in Group III between days 1 and 7 before reverting to the starting levels by day 27. From these results, it can be seen that probiotic supplementation modulates the response of the intestinal microflora to the effects of antibiotic therapy.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Clinical trials have demonstrated that the inclusion of Lactobacillus strains CUL-60 and CUL-21 modulated facultative anaerobes during antibiotic therapy.
“Clinical trials, however, have demonstrated that the inclusion of the Lactobacillus strains CUL-60 and CUL-21 modulated the facultative anaerobes (Enterobacteriaceae, Enteroccus/Streptococcus and Staphylococcus species) during antibiotic therapy [24,55].”
Cites
Probiotics: effects on immunity
Isolauri, E., Sütas, Y., Kankaanpää, P., Arvilommi, H. S., & Salminen, S. (2001) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.444s · Cited by 1,021 · see citing works
Effect of antimicrobial agents on the ecological balance of human microflora
Sullivan, Å., Edlund, C., & Nord, C. E. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00066-4 · Cited by 816 · see citing works
Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis
D'Souza, A. L., Rajkumar, C., Cooke, J., & Bulpitt, C. J. (2002) · BMJ · doi:10.1136/bmj.324.7350.1361 · Cited by 664 · see citing works
Ecological control of the gastrointestinal tract. The role of probiotic flora
Bengmark, S. (1998) · Gut · doi:10.1136/gut.42.1.2 · Cited by 505 · see citing works
Meta‐analysis: the effect of probiotic administration on antibiotic‐associated diarrhoea
Cremonini, F., Caro, S. D., Nista, E. C., Bartolozzi, F., Capelli, G., Gasbarrini, A., & Gasbarrini, A. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01318.x · Cited by 385 · see citing works
Probiotic immunomodulation in health and disease
Erickson, K. L., & Hubbard, N. E. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.2.403s · Cited by 372 · see citing works
Probiotics, infection and immunity
Macfarlane, G. T., & Cummings, J. H. (2002) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200210000-00008 · Cited by 185 · see citing works
A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics
Madden, J. A. J., & Hunter, J. O. (2002) · British Journal Of Nutrition · doi:10.1079/bjn2002631 · Cited by 174 · see citing works
Antibiotic use, childhood affluence and irritable bowel syndrome (IBS)
Mendall, M. A., & Kumar, D. (1998) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199801000-00011 · Cited by 155 · see citing works
Adamsson, I., Nord, C. E., Lundquist, P. G., Sjöstedt, S., & Edlund, C. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.5.629 · Cited by 146 · see citing works
HALPERN, G. M., Prindiville, T. P., Blankenburg, M., Hsia, T., & Gershwin, M. E. (1996) · PubMed · Cited by 131 · see citing works
Lactobacilli and the Normal Human Anaerobic Microflora
Lidbeck, A., & Nord, C. E. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/16.supplement_4.s181 · Cited by 107 · see citing works
Black, F. T., Einarsson, K., Lidbeck, A., Orrhage, K., & Nord, C. E. (1991) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549109023408 · Cited by 92 · see citing works
Bühling, A., Radun, D., Müller, W. A., & Malfertheiner, P. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01033.x · Cited by 81 · see citing works
Agréus, L., Engstrand, L. G., Svärdsudd, K., Nyrén, O., & Tibblin, G. (1995) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529509096323 · Cited by 78 · see citing works
Orrhage, K., Sjöstedt, S., & Nord, C. E. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.4.603 · Cited by 70 · see citing works
Interaction of Antimicrobial Therapy and Intestinal Flora
Finegold, S. M. (1970) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/23.11.1466 · Cited by 67 · see citing works
Impact of cefpodoxime proxetil and amoxicillin on the normal oral and intestinal microflora
Brismar, B., Edlund, C., & Nord, C. E. (1993) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02009388 · Cited by 57 · see citing works
Stark, C., Adamsson, I., Edlund, C., Sjösted, S., Seensalu, R., Wikström, B., & Nord, C. E. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/38.6.927 · Cited by 52 · see citing works
Lidbeck, A., Edlund, C., Gustafsson, J.-Α., Kager, L., & Nora, C. (1988) · Infection · doi:10.1007/bf01644541 · Cited by 50 · see citing works
The effect of antimicrobial agents on the ecology of the human intestinal microflora
Nord, C. E. (1993) · Veterinary Microbiology · doi:10.1016/0378-1135(93)90144-v · Cited by 49 · see citing works
Effect of antimicrobial therapy on bowel flora.
Hooker, K. D., & DiPiro, J. T. (1988) · PubMed · Cited by 37 · see citing works
Risk of diarrhoea, Clostridium difficile and cefotaxime in the elderly
Starr, J. M., & Impallomeni, M. (1997) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(97)87728-1 · Cited by 16 · see citing works
Kawamura, A., Adachi, K., Takashima, T., Yuki, M., Ono, M., & Kinoshita, Y. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03910.x · Cited by 13 · see citing works
Krook, A. L., Kjellander, J., & Danielsson, D. G. (1982) · Scandinavian Journal of Infectious Diseases · doi:10.3109/inf.1982.14.issue-1.09 · Cited by 7 · see citing works
Pharmacokinetic differentiation and consequences for normal microflora.
Bergan, T. (1986) · PubMed · Cited by 7 · see citing works
The dawning of the once-a-day era
Moyle, G. J. (2002) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200202000-00001 · Cited by 3 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Goldenberg, J. Z., Ma, S. S., Saxton, J. D., Martzen, M. R., Vandvik, P. O., Thorlund, K., Guyatt, G. H., & Johnston, B. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006095.pub3 · Cited by 741 · see citing works
Traditional Cheeses: Rich and Diverse Microbiota with Associated Benefits
Montel, M.-C., Buchin, S., Mallet, A., Delbes-Paus, C., Vuitton, D. A., Desmasures, N., & Berthier, F. (2014) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2014.02.019 · Cited by 665 · see citing works
“Ingestion of large quantities of LAB (independently of milk products) may indeed have a positive effect on bowel movements during antibiotherapy and on the enteric microbiota in healthy volunteers (Koning et al., 2008; Madden et al., 2005; Plummer et al., 2005).”
BackgroundProbiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Goldenberg, J. Z., Yap, C., Lytvyn, L., Lo, C. K.-F., Beardsley, J., Mertz, D., & Johnston, B. C. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006095.pub4 · Cited by 550 · see citing works
Kumar, P., Leys, E. J., Bryk, J., Martinez, F. J., Moeschberger, M. L., & Griffen, A. L. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00317-06 · Cited by 318 · see citing works
“For example, colonization stability has been studied in the gastrointestinal tract, where colonization with normal flora decreases susceptibility to infections by exogenous pathogens such as Salmonella or Clostridium spp. (1, 23).”
BackgroundInfluentialQuestions asked and answered in pilot and feasibility randomized controlled trials
Shanyinde, M., Pickering, R. M., & Weatherall, M. (2011) · BMC Medical Research Methodology · doi:10.1186/1471-2288-11-117 · Cited by 229 · see citing works
“Using computer generated random numbers we selected 50 of those identified for full review [10-59].”
MethodTONG, J. L., Ran, Z. H., Shen, J., Zhang, C.-J., & Xiao, S. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03179.x · Cited by 256 · see citing works
McFarland, L. V. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005047 · Cited by 235 · see citing works
Govender, M., Choonara, Y. E., Kumar, P., du Toit, L. C., van Vuuren, S. F., & Pillay, V. (2013) · AAPS PharmSciTech · doi:10.1208/s12249-013-0027-1 · Cited by 215 · see citing works
Are Putative Periodontal Pathogens Reliable Diagnostic Markers?
Riep, B., Edesi-Neuß, L., Claessen, F., Skarabis, H., Ehmke, B., Flemmig, T. F., Bernimoulin, J., Göbel, U. B., & Moter, A. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01387-08 · Cited by 162 · see citing works
“This approach has been studied in the gastrointestinal tract by use of probiotics or microbial replacement therapy (17) and deserves further investigation in the treatment of periodontitis.”
BackgroundWILLIAMS, E. A., STIMPSON, J., WANG, D., PLUMMER, S., GARAIOVA, I., BARKER, M. E., & CORFE, B. M. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03848.x · Cited by 156 · see citing works
Self-citationMcFarland, L. V., Huang, Y., Wang, L., & Malfertheiner, P. (2015) · United European Gastroenterology Journal · doi:10.1177/2050640615617358 · Cited by 156 · see citing works
Probiotics: Role in Pathophysiology and Prevention in Necrotizing Enterocolitis
Martin, C. R., & Walker, W. A. (2008) · Seminars in Perinatology · doi:10.1053/j.semperi.2008.01.006 · Cited by 132 · see citing works
Wolvers, D., Antoine, J.-M., Myllyluoma, E., Schrezenmeir, J., Szajewska, H., & Rijkers, G. T. (2010) · The Journal of Nutrition · doi:10.3945/jn.109.113753 · Cited by 268 · see citing works
Brunser, O., Gotteland, M., Cruchet, S., Figueroa, G., Garrido, D. A., & Steenhout, P. G. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000198773.40937.61 · Cited by 127 · see citing works
“bifidum) after an antibiotic treatment for Helicobacter pylori (19).”
BackgroundProbiotic fermented foods for health benefits
Divya, J. B., Varsha, K. K., Nampoothiri, K. M., Ismail, B., & Pandey, A. (2012) · Engineering in Life Sciences · doi:10.1002/elsc.201100179 · Cited by 110 · see citing works
“and total numbers of antibiotic-resistant strains in the regrowth population [44, 45].”
BackgroundClinical application of probiotics in the treatment of Helicobacter pylori infection—A brief review
Patel, A. R., Shah, N., & Prajapati, J. B. (2013) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2013.03.010 · Cited by 105 · see citing works
Koning, C. J., Jonkers, D. M. A. E., Stobberingh, E. E., Mulder, L. H. C., Rombouts, F. M., & Stockbrügger, R. W. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01547.x · Cited by 100 · see citing works
“Furthermore, antibiotic use and the subsequent disturbance of the intestinal microbiota is a risk factor for the development of irritable bowel syndrome (11, 12).”
BackgroundRoberts, J., Suckling, C., Peedle, G., Murphy, J., Dawkins, T., & Roberts, M. (2016) · Nutrients · doi:10.3390/nu8110733 · Cited by 99 · see citing works
Probiotics in Clinical Practice: An Overview
Zuccotti, G., Meneghin, F., Raimondi, C., Dilillo, D., Agostoni, C. V., Riva, E., & Giovannini, M. (2008) · Journal of International Medical Research · doi:10.1177/14732300080360s101 · Cited by 99 · see citing works
Akkermansia muciniphila: a potential candidate for ameliorating metabolic diseases
Niu, H., Zhou, M., Zogona, D., Xing, Z., Wu, T., Chen, R., Cui, D., Liang, F., & Xu, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1370658 · Cited by 98 · see citing works
Effects of anti-Helicobacter pylori treatment and probiotic supplementation on intestinal microbiota
Myllyluoma, E., Ahlroos, T., Veijola, L., Rautelin, H., Tynkkynen, S., & Korpela, R. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.08.034 · Cited by 95 · see citing works
Probiotics in the next-generation sequencing era
Suez, J., Zmora, N., & Elinav, E. (2019) · Gut Microbes · doi:10.1080/19490976.2019.1586039 · Cited by 82 · see citing works
An HPLC-DAD method for the simultaneous determination of nine β-lactam antibiotics in ewe milk
Cámara, M., Gallego-Picó, A., Martı́nez, R. M. G., Hernando, P. F., Durand-Alegría, J. S., & Sánchez, P. J. (2013) · Food Chemistry · doi:10.1016/j.foodchem.2013.02.131 · Cited by 81 · see citing works
Probiotics as functional food in the treatment of diarrhea
Yan, F., & Polk, D. B. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000247477.02650.51 · Cited by 80 · see citing works
Éliás, A. J., Barna, V., Patoni, C., Demeter, D., Veres, D. S., Bunduc, Ș., Erőss, B. M., Hegyi, P., Földvári-Nagy, L., & Lenti, K. (2023) · BMC Medicine · doi:10.1186/s12916-023-02961-0 · Cited by 72 · see citing works
Probiotic Modulation of the Gut Microbiota of Fish
Merrifield, D. L., & Carnevali, O. (2014) · Aquaculture Nutrition · doi:10.1002/9781118897263.ch8 · Cited by 73 · see citing works
Probiotics: Delineation of Prophylactic and Therapeutic Benefits
Kaur, I. P., Kuhad, A., Garg, A., & Chopra, K. (2009) · Journal of Medicinal Food · doi:10.1089/jmf.2007.0544 · Cited by 66 · see citing works
“37,38 Madden et al .”
Divya, J. B., Varsha, K. K., & Nampoothiri, K. M. (2012) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-012-9561-7 · Cited by 65 · see citing works
Surawicz, C. M. (2008) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181646d09 · Cited by 62 · see citing works
Ye, Q., Shao, X., Shen, R., Chen, D., & Shen, J. (2020) · Helicobacter · doi:10.1111/hel.12713 · Cited by 53 · see citing works
Analysis of treatment effects on the microbial ecology of the human intestine
Engelbrektson, A. L., Korzenik, J. R., Sanders, M. E., Clement, B., Leyer, G. J., Klaenhammer, T. R., & Kitts, C. L. (2006) · FEMS Microbiology Ecology · doi:10.1111/j.1574-6941.2006.00112.x · Cited by 51 · see citing works
Saarela, M., Maukonen, J., von Wright, A., Vilpponen-Salmela, T., Patterson, A. J., Scott, K. P., Hämynen, H., & Mättö, J. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.09.020 · Cited by 48 · see citing works
Probiotics as an adjuvant treatment in Helicobacter pylori eradication therapy
Zhu, X. Y., & Liu, F. (2017) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12466 · Cited by 47 · see citing works
Yin, Y., Wang, C., Liu, X., Cui, Y., Xie, N., Yu, Q.-F., Li, F., & Lu, F. (2011) · Helicobacter · doi:10.1111/j.1523-5378.2011.00862.x · Cited by 45 · see citing works
Mouthguards: does the indigenous microbiome play a role in maintaining oral health?
Kumar, P., & Mason, M. R. (2015) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2015.00035 · Cited by 36 · see citing works
“On the other hand, replenishing the resident microbiome using probiotics has been shown to reverse the effects of antibiotic-induced pathogen disease in the urinary tract, gut, and the dentition (Madden et al., 2005; Whorwell et al., 2006; Amdekar et al., 2011; Culp et al., 2011).”
Interspecies comparison of probiotics isolated from different animals
Abdou, A. M., Hedia, R. H., Omara, S. T., Mahmoud, M. A. E.-F., Kandil, M. M., & Bakry, M. A. (2018) · Veterinary World · doi:10.14202/vetworld.2018.227-230 · Cited by 33 · see citing works
“Probiotics are likely to have an impact through gut mucosa by balancing the local microbiota [17], by inhibiting the growth of pathogenic microorganisms [18], and by enhancing local and systemic immune responses [19].”
BackgroundAntibiotic residues and mycotoxins in raw milk in Punjab (India): a rising concern for food safety
Moudgil, P., Bedi, J. S., Aulakh, R. S., & Gill, J. P. S. (2019) · Journal of Food Science and Technology · doi:10.1007/s13197-019-03963-8 · Cited by 33 · see citing works
Inhibitory effects of Lactobacillus fermentum on microbial growth and biofilm formation
Рыбальченко, О. В., Бондаренко, В. М., Орлова, О. Г., Markov, A. G., & Amasheh, S. (2015) · Archives of Microbiology · doi:10.1007/s00203-015-1140-1 · Cited by 32 · see citing works
“Normal microflora prevents the spread of opportunistic pathogens bacteria from these biotopes and their translocation into the systemic circulation (Madden et al. 2005; Manzoni 2007).”
Sun, J., Gan, T., Zhu, H., Shi, Z., & Liu, Y. (2014) · Applied Clay Science · doi:10.1016/j.clay.2014.09.025 · Cited by 31 · see citing works
“, 1991), or affected the intestinal flora (Madden et al., 2005).”
BackgroundShimada, T., Cheng, L., Shi, H., Hayashi, A., Motonaga, C., Tang, J., Enomoto, K., & Enomoto, T. (2007) · PubMed · Cited by 20 · see citing works
The Use of Probiotics in Helicobacter pylori Eradication Therapy
Medeiros, J. A., & Pereira, M.-I. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182702dbc · Cited by 20 · see citing works
Ezaki, S., Itoh, K., Kunikata, T., Suzuki, K., Sobajima, H., & Tamura, M. (2012) · Allergology International · doi:10.2332/allergolint.11-oa-0305 · Cited by 18 · see citing works
Effects of Helicobacter pylori Therapy on Gut Microbiota: A Systematic Review and Meta-Analysis
Du, L., Chen, B., Cheng, F., Kim, J. J., & Kim, J. J. (2022) · Digestive Diseases · doi:10.1159/000527047 · Cited by 16 · see citing works
Zhang, Y., Lu, B., Dong, Y., Zhang, Y., Du, Q., Chen, Y., & Zhang, Z. (2024) · Scientific Reports · doi:10.1038/s41598-024-63894-z · Cited by 14 · see citing works
“In light of emerging trends, microbiota research has gained prominence, prompting increased scholarly interest in harnessing probiotics as novel therapeutic regimens or supplementary agents for anti-Helicobacter pylori treatment 8,21 .”
BackgroundHuman Gut Microbiota in Heart Failure: Trying to Unmask an Emerging Organ
PARASKEVAIDIS, I. A., Xanthopoulos, A. V., Tsougos, E., & Triposkiadis, F. K. (2023) · Biomedicines · doi:10.3390/biomedicines11092574 · Cited by 13 · see citing works
Bertrand, X., Dufour, V., Millon, L., Beuvier, É., Gbaguidi‐Haore, H., Piarroux, R., Vuitton, D. A., & Talon, D. R. (2006) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2006.03148.x · Cited by 11 · see citing works
“Recent studies suggest that supplementation with Lactobacillus strains during antibiotic therapy reduces the occurrence of antibiotic-resistant enterococci in the regrowth population (Madden et al. 2005; Plummer et al. 2005).”
MethodResultLi, Y., Zhang, Y., Zhao, J., Zhang, X., Liu, S., He, Q., Qiao, F., & Yao, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39539 · Cited by 8 · see citing works
“…strains also has advantages, such as the ability to survive in the intestinal tract when taking antibiotics, which is conducive to intestinal colonization to help restore the homeostasis of intestinal flora and alleviate the problem of gastrointestinal flora imbalance caused by antibiotics [33,34].”
BackgroundMicrobiological Considerations for Probiotic Supplemented Foods
Quality Assurance, M. D. L., & Sarkar, S. (2013) · International Journal of Microbiology & Advanced Immunology · doi:10.19070/2329-9967-130001 · Cited by 8 · see citing works
“Beneficial health effects extend by probiotics is due to maintenance of the equilibrium of indigenous microbiota [11] with the growth inhibition of pathogenic microorganisms and boosting of innate and acquired immunity [12].”
BackgroundHatakka, K. (2007) · Työväentutkimus Vuosikirja · Cited by 8 · see citing works
Guo, Q., Yang, X., Chen, Z., Wang, G., Yao, L., & Lin, Z. (2021) · Journal of Materials Science Materials in Electronics · doi:10.1007/s10854-021-07316-0 · Cited by 7 · see citing works
“Moreover, continued consumption of food containing sublethal level of antibiotics may also cause anaphylactic reactions in sensitive people [9], affect the normal activities of intestinal flora [10], and even induce hepatotoxicity [11].”
BackgroundKim, J.-C., Yoon, B., & Jeon, Y. K. (2020) · Healthcare · doi:10.3390/healthcare9010007 · Cited by 7 · see citing works
“Previous studies have indicated that probiotics significantly influence immune function [9,10] by increasing immune cell proliferation and sensitivity to external antigens [11,12].”
BackgroundUse of a multi-species probiotic
Lang, F. C. (2010) · Nutrafoods · doi:10.1007/bf03223333 · Cited by 7 · see citing works
The role of probiotics in Helicobacter pylori infection
Myllyluoma, E. (2007) · Työväentutkimus Vuosikirja · Cited by 7 · see citing works
Paduchová, Z., Nagyová, Z., Wang, D., & Muchová, J. (2024) · Nutrition Research and Practice · doi:10.4162/nrp.2024.18.1.98 · Cited by 6 · see citing works
Kim, J.-C., & Lee, S. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105311 · Cited by 5 · see citing works
Common Nutrient Depletions Caused by Pharmaceuticals
Meletis, C. D., & Zabriskie, N. (2007) · Alternative and Complementary Therapies · doi:10.1089/act.2006.13102 · Cited by 5 · see citing works
Lehtoranta, L. (2012) · Työväentutkimus Vuosikirja · Cited by 5 · see citing works
Early-life antibiotic exposures: Paving the pathway for dysbiosis-induced disorders
Attiq, A. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177298 · Cited by 4 · see citing works
Sequencing analysis and characterization of the plasmid pBIF10 isolated from Bifidobacterium longum
Ma, Y., Xie, T., Hu, Q., Qiu, Z., & Song, F. (2014) · Canadian Journal of Microbiology · doi:10.1139/cjm-2014-0581 · Cited by 4 · see citing works
“Because of their beneficial effects on the health of host, bifidobacteria have attracted the attention of scientists (Bartosch et al. 2005; Kliegman 2005; Kliegman and Willoughby 2005; Madden et al. 2005).”
BackgroundScărlătescu, A. I., Velescu, B. Ș., Apetroaei, M.-M., Nedea, M. I., Udeanu, D. I., & Arsene, A. L. (2024) · Processes · doi:10.3390/pr12091856 · Cited by 3 · see citing works
Gastrointestinal Benefits of Probiotics
Ouwehand, A. C. (2019) · CRC Press eBooks · doi:10.1201/9780429057465-25 · Cited by 3 · see citing works
Koning, C. J. (2010) · doi:10.26481/dis.20100604ck · Cited by 3 · see citing works
Chen, B., Li, X.-M., Cai, T., & Wang, F. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.913384 · Cited by 2 · see citing works
Functional Dairy Products and Probiotics in Infectious Diseases
Çırak, M. Y. (2009) · CRC Press eBooks · doi:10.1201/9781420082081-c14 · Cited by 2 · see citing works
Probiotics in Paediatric Disorders
Kaur, I. P., Chopra, A., & Chopra, K. (2006) · International Journal of Pharmaceutical Medicine · doi:10.2165/00124363-200620010-00004 · Cited by 2 · see citing works
“[24] Madden et al.[58] reported that probiotic supplementation modulates the response of the intestinal microflora to the effects of antibiotic therapy.”
BackgroundCoates, N., John, D. A., Jordan, S. E., Storey, M., Thornton, C. A., Garaiová, I., Wang, D., Allen, S. J., Michael, D. R., Plummer, S., et al. (2025) · Microorganisms · doi:10.3390/microorganisms13050984 · Cited by 1 · see citing works
“…their arrival at the laboratory, with selective agars used to quantify viable Lactobacilli , Bifidobacteria , Enterobacter , Enterococci , Bacteroides , Staphylococci , Streptococci , and Clostridia , as well as yeast, total aerobes, and total anaerobes, following the method of Madden et al. [26].”
Probiotics and Antibiotic-Associated Diarrhea and Clostridium difficile Infection
Surawicz, C. M. (2009) · Springer eBooks · doi:10.1007/978-0-387-79058-9_21 · Cited by 1 · see citing works
Probiotics Usage in Childhood Helicobacter pylori Infection
Anania, C., Celani, C., Chiesa, C., & Pacifico, L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-802189-7.00051-4 · Cited by 1 · see citing works
Functional dairy products for gastrointestinal infections and dysfunction
Myllyluoma, E., Kajander, K., & Saxelin, M. (2007) · Elsevier eBooks · doi:10.1533/9781845693107.1.63 · Cited by 1 · see citing works
Bohlin, M. (2006) · Epsilon Archive for Student Projects (University of Southampton) · Cited by 1 · see citing works
Steele, S. E. (2008) · Digital Commons - University of South Florida (University of South Florida)
Gut microbiota and atopic manifestations in infancy
Penders, J. (2007) · doi:10.26481/dis.20070330jp
Hevosen ruokinta, terveys ja suolistomikrobisto
Huttunen, A. (2013) · Theseus (Ammattikorkeakoulujen)
Galvin, K., & Bishop, M. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7295-3955-5.10006-x
Wen, B. (2015) · TSpace (University of Toronto)
Park, K., & Kim, J.-C. (2021) · Physikalische Medizin Rehabilitationsmedizin Kurortmedizin · doi:10.1055/a-1493-4911
“This result is consistent with previous findings that probiotics and exercise increase GABA [15, 42].”
ResultKuhad, A., Kaur, I. P., Chopra, K., & Garg, A. (2009) · CRC Press eBooks · doi:10.1201/9781420062151.ch18
Probiotics in Infectious Diseases
Fong, I. W. (2009) · Springer eBooks · doi:10.1007/978-0-387-84841-9_10
Galvin, K., & Bishop, M. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7295-3955-5.10009-5
Sanders, M. E. (2014) · ASM Press eBooks · doi:10.1128/9781555815462.ch1
Éliás, A. J., Barna, V., Patoni, C., Demeter, D., Veres, D. S., Bunduc, Ș., Erőss, B. M., Hegyi, P. J., Földvári-Nagy, L., & Lenti, K. (2023) · Figshare · doi:10.6084/m9.figshare.23714166
Application of novel biomaterials for oral probiotic
Nivethini, D., & Chitra, A. V. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27594-4.00021-8
Éliás, A. J., Barna, V., Patoni, C., Demeter, D., Veres, D. S., Bunduc, Ș., Erőss, B., Hegyi, P., Földvári-Nagy, L., & Lenti, K. (2023) · Figshare · doi:10.6084/m9.figshare.23714160
Éliás, A. J., Barna, V., Patoni, C., Demeter, D., Veres, D. S., Bunduc, Ș., Erőss, B., Hegyi, P., Földvári-Nagy, L., & Lenti, K. (2023) · Figshare · doi:10.6084/m9.figshare.23714163
Microorganismos probióticos y la modulación inmunológica
Fierro, J. A. A., Ortega, J. A., & Contreras, J. P. R. (2006) · Universidad Industrial de Santander
- Authors
- Madden, J. A. J., Plummer, S. F., Tang, J., Garaiova, I., Plummer, N. T., Herbison, M., Hunter, J. O., Shimada, T., Cheng, L., & Shirakawa, T.
- Affiliations
- Cultech (United Kingdom) (GB)
- Addenbrooke's Hospital (GB)
- Kyoto University (JP)
- Corresponding author
- Plummer, Susan F.
- Venue
- International Immunopharmacology
- Publisher
- Elsevier BV
- Published
- 2005-06
- Volume
- 5
- Issue
- 6
- Pages
- 1091-1097
- ISSN
- 1567-5769 (ISSN-L)
- OpenAlex
- W2150842395
- Cited by
- 86
- References
- 27
- Citations by year
- 2025: 3 · 2024: 5 · 2023: 5 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 1 · 2017: 2 · 2016: 1 · 2015: 5 · 2014: 7 · 2013: 6 · 2012: 5
- FWCI
- 12.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Immunopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- probiotics, H. pylori eradication therapy, antibiotic-induced dysbiosis, gut microbiota, Lactobacillus acidophilus, Bifidobacterium bifidum, facultative anaerobes, anaerobic bacteria, probiotic supplementation
- MeSH terms
- Aged, Anti-Bacterial Agents, Bacteria, Anaerobic, Double-Blind Method, Female, Humans, Intestines, Male, Middle Aged, Patient Compliance, Pilot Projects, Colony Count, Microbial, Helicobacter pylori, Helicobacter Infections, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review